About 1 result found for searched term "2416131-46-7" (0.091 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M43813 | NX-2127 | BTK |
| Zelebrudomide | ||
| Zelebrudomide (NX-2127) is an orally active, potent BTK inhibitor that induces degradation of mutant BTKC481S in cells, as well as inhibits the proliferation of BTKC481S mutant TMD8 cells. In addition, NX-2127 stimulates T cell activation and increases IL-2 production in primary human T cells. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
